Arthroscopy Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Arthroscopes, Arthroscopic implants, Other instruments and accessories), By Application (Spine, Foot and ankle, Hips, Shoulder and elbow), By End User (Hospitals, Orthopaedic clinics, Others) and Region Forecast 2021-2032

Arthroscopy Devices Market size was valued at US$ 8.1 billion in 2025 and is expected to reach US$ 13.9 billion by 2032, growing at a significant CAGR of 8.1% from 2026-2032. Arthroscopy is a specific examination of inside structures of a joint. The process of arthroscopy includes insertion of a specifically designed illuminated device into a joint through the small incision. This procedure is primarily associated with diagnosis process. Arthroscopy is an instrument which consists of magnifying lenses and glass coated fibres, enables send concentrated lights into the joint and a camera is attached to arthroscopy device. This allows the surgeon to have a clear view of joint, thus obtained image is transferred to the monitor during arthroscopy in an operating room.

Arthroscopic devices are one of the emerging and attractive industry in medical devices sector. In recent times orthopaedic field has seen major private equity transactions, several mergers and innovation of new products which is the major factor expected to fuel the growth of market. As people are becoming more conscious about their health, they are preferring the high layout of quality orthopaedic treatments, growing the ageing population, rising technological advancements in medical and healthcare sector, increase in usage of robotics are few factors which are fuelling the growth of the market.

In addition, greater precision to perform surgeries of highly sensitive areas like spine, minimal post-operative complications, a rise in obese patients causing degradation of bone are few factors which are expected to witness the growth of the market. However, lack of skilled professionals and a high cost of arthroscopic devices expected to dampen the market.

Key Developments:

• In 2017 June, Zimmer Biomet Holdings, Inc. introduced X-ray-based patient specific instrument named X-PSI knee system. It is the first CE marked surgical planning system in the world. In March 2017, Stryker commercially launched highly anticipated robotic arm assisted total knee arthroplasty system in U.S